CVS CEO shakes up leadership team with new CFO and medical officer

In the United States, CVS Health announced significant leadership changes as CEO David Joyner appointed Brian Newman as the new chief financial officer and Dr. Amy Compton-Phillips as the chief medical officer. The announcement was made on April 8, 2025, as part of Joyner's efforts to build a strong management team following his CeO appointment less than six months prior. Brian Newman, 56, is set to take over as the executive vice president and chief financial officer on April 21, after previously serving in the same role at United Parcel Service, where he successfully navigated the challenges presented by the COVID-19 pandemic. He will be succeeding Tom Cowhey, the outgoing CFO, who will become a strategic advisor to Joyner effective May 12. Similarly, Dr. Amy Compton-Phillips, 61, will join the management team as the chief medical officer on May 19, bringing her extensive background in healthcare from her previous role as chief physician executive at Press Ganey. Joyner expressed confidence in their capabilities to support CVS Health’s strategic goals and to provide improved health care for its vast customer base. These appointments are viewed as a crucial step in addressing CVS's ongoing struggles with cost control, particularly in its Aetna health insurance operations and its retail pharmacy sector. Despite these challenges, the company is optimistic about its financial outlook, anticipating that results will potentially meet or exceed the previously issued forecasts for 2025. CVS Health is expected to report its first-quarter earnings on May 1, and the financial closing procedures for that period are still underway. Joyner's moves are the first significant appointments since he took the helm of CVS last October, following the departure of his predecessor, Karen S. Lynch.